Previous Blogs

Avatar

By Melanie Prudom

November 16, 2020

West was pleased to recently attend the U.S. FDA’s first Compounding Center of Excellence Conference “Working Together for Patient Safety” on September 21st and 22nd. The virtual conference brought together current and future outsourcing facilities, state and federal regulators, experts, trade organizations and other industry stakeholders to learn and engage on key topics and best practices.

Avatar

By Amy Kim

July 10, 2019

In 2015, the FDA shed light on a problematic practice within the healthcare industry involving improper, off-label use of syringes as closed container storage systems for compounded or repackaged drugs. The incidents cited revealed that interaction with rubber plungers in syringes that were not cleared for the purpose of closed container storage resulted in the loss of potency of several drugs when administration was delayed.1

Avatar

By Melanie Prudom

June 13, 2019

Members of the West Pharmaceutical Services, Inc. (West) Marketing Unit had the pleasure of attending the recent FDA Public Meeting on Tuesday, May 21, 2019 regarding 503B Compounding Pharmacies and the cGMP draft guidance, as well as office stock issues which had generated many comments.